Global Urinary Incontinence Treatment Devices Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Product;

Urethral Slings - Female Slings and Male Slings, Electrical Stimulation Devices - Implantable and Non-Implantable, and Artificial Urinary Sphincters.

By Incontinence;

Stress Urinary Incontinence, Urge Urinary Incontinence, Mixed Incontinence, and Overflow Incontinence.

By Category;

Internal Incontinence Devices and External Incontinence Devices.

By End User;

Hospitals, Ambulatory Surgery Centers, Clinics, and Home Care.

By Geography;

North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2021 - 2031).
Report ID: Rn568998144 Published Date: January, 2025 Updated Date: February, 2025

Introduction

Global Urinary Incontinence Treatment Devices Market (USD Million), 2021 - 2031

In the year 2024, the Global Urinary Incontinence Treatment Devices Market was valued at USD 6,728.03 million. The size of this market is expected to increase to USD 11,249.64 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 7.6%.

The global urinary incontinence treatment devices market has been witnessing steady growth over the past decade, fueled by a rising prevalence of urinary incontinence, particularly among the aging population worldwide. Urinary incontinence, a common condition characterized by the loss of bladder control, has emerged as a significant public health concern, prompting increased demand for effective treatment options. As a result, manufacturers have been actively innovating and introducing advanced urinary incontinence treatment devices to address the diverse needs of patients.

One of the key drivers propelling market growth is the growing awareness regarding urinary incontinence and its impact on the quality of life. With greater understanding and acceptance of this condition, more individuals are seeking medical intervention and management solutions, thereby driving the demand for urinary incontinence treatment devices. Additionally, advancements in medical technology have led to the development of minimally invasive and highly efficacious devices, offering patients safer and more convenient treatment options.

The expanding geriatric population, particularly in developed regions, is anticipated to bolster market expansion. Aging is a major risk factor for urinary incontinence, and as the elderly population grows, the prevalence of this condition is expected to rise significantly, necessitating the adoption of urinary incontinence treatment devices. Moreover, favorable government initiatives aimed at promoting awareness about urinary incontinence and improving access to healthcare services are likely to further stimulate market growth in the coming years.

Despite the promising prospects, the market faces challenges such as high costs associated with advanced treatment devices and limited reimbursement policies in certain regions. Nevertheless, ongoing research and development activities aimed at introducing cost-effective solutions and expanding market reach are anticipated to mitigate these challenges, fostering continued growth in the global urinary incontinence treatment devices market.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Product
    2. Market Snapshot, By Incontinence
    3. Market Snapshot, By Category
    4. Market Snapshot, By End User
    5. Market Snapshot, By Region
  4. Global Urinary Incontinence Treatment Devices Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Aging population
        2. Technological advancements
        3. Increasing awareness about treatment
        4. Growing healthcare expenditure
      2. Restraints
        1. High cost of devices
        2. Limited reimbursement policies
        3. Social stigma
        4. Lack of skilled professionals
      3. Opportunities
        1. Emerging markets
        2. Innovative product development
        3. Telemedicine and remote monitoring
        4. Strategic partnerships and collaborations
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Global Urinary Incontinence Treatment Devices Market, By Product, 2021 - 2031 (USD Million)
      1. Urethral Slings
        1. Female Slings
        2. Male Slings
      2. Electrical Stimulation Devices
        1. Implantable
        2. Non-Implantable
      3. Artificial Urinary Sphincters
    2. Global Urinary Incontinence Treatment Devices Market, By Incontinence, 2021 - 2031 (USD Million)
      1. Stress Urinary Incontinence
      2. Urge Urinary Incontinence
      3. Mixed Incontinence
      4. Overflow Incontinence
    3. Global Urinary Incontinence Treatment Devices Market, By Category, 2021 - 2031 (USD Million)
      1. Internal Incontinence Devices
      2. External Incontinence Devices
    4. Global Urinary Incontinence Treatment Devices Market, By End User, 2021 - 2031 (USD Million)
      1. Hospitals
      2. Ambulatory Surgery Centers
      3. Clinics
      4. Home Care
    5. Global Urinary Incontinence Treatment Devices Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Boston Scientific Corporation
      2. C.R. Bard, Inc
      3. Ethicon
      4. Coloplast A/S
      5. Medtronic plc
      6. Kimberly-Clark Corporation
      7. Hollister Incorporated
      8. Teleflex Incorporated
      9. ConvaTec Group plc
      10. B. Braun Melsungen AG
  7. Analyst Views
  8. Future Outlook of the Market